Choosing the Appropriate Salvage Therapy for B-Cell Non-Hodgkin Lymphoma

Expert Opinion on Pharmacotherapy - United Kingdom
doi 10.1080/14656566.2018.1518430
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Timing of Salvage Therapy and Autologous Hematopoietic Cell Transplant in Relapsed Hodgkin and Non Hodgkin Lymphoma

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

MicroRNA Dysregulation in B-Cell Non-Hodgkin Lymphoma

Blood and Lymphatic Cancer: Targets and Therapy
2013English

Expression of PAX-5 in B Cell Hodgkin and Non Hodgkin Lymphoma

Asian Pacific Journal of Cancer Prevention
2018English

Hepatitis C Associated B-Cell Non-Hodgkin Lymphoma: Clinical Features and the Role of Antiviral Therapy

Journal of Clinical and Translational Hepatology
2015English

Subcutaneous Rituximab in B-Cell Non-Hodgkin Lymphoma: A Single-Center Experience

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2017English

Regulation of CD20 in Rituximab-Resistant Cell Lines and B-Cell Non-Hodgkin Lymphoma

Clinical Cancer Research
Cancer ResearchOncology
2012English

Autologous Stem Cell Transplantation Outcomes in Elderly Patients With B Cell Non-Hodgkin Lymphoma

British Journal of Haematology
Hematology
2015English

Emerging Role of Podocalyxin in the Progression of Mature B-Cell Non-Hodgkin Lymphoma

Cancers
Cancer ResearchOncology
2020English

Non-Hodgkin Lymphoma

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy